David Kline to Cardiovascular Agents
This is a "connection" page, showing publications David Kline has written about Cardiovascular Agents.
Connection Strength
0.146
-
Arnold WD, Kline D, Sanderson A, Hawash AA, Bartlett A, Novak KR, Rich MM, Kissel JT. Open-label trial of ranolazine for the treatment of myotonia congenita. Neurology. 2017 Aug 15; 89(7):710-713.
Score: 0.146